MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2025 Positive…
MaaT PharmaMay 13, 2025
MaaT Pharma Announces Initiation of Coverage of its Stock by H.C. Wainwright & Co Lyon,…
MaaT PharmaApril 7, 2025
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaApril 4, 2025
MaaT Pharma Completes a Capital Increase of €13 Million with Historical Shareholders and Announces 2024…
MaaT PharmaMarch 27, 2025
MaaT Pharma Announces Positive Topline Results from the Pivotal Phase 3 ARES Study Evaluating MaaT013…
MaaT PharmaJanuary 8, 2025
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaJanuary 7, 2025
MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes Completion…
MaaT PharmaNovember 5, 2024
MaaT Pharma Publishes its Half Year 2024 Results and Provides a Business Update Positive…
MaaT PharmaSeptember 19, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaSeptember 9, 2024
